Protocol-driven auricular tVNS with credible research provenance — strong on EU regulatory and trial backing.Best for users in EU markets who want protocol variety with thinner evidence than Nurosym.
Vagustim is a Turkish-developed auricular tVNS device, CE-marked and backed by a published trial base from clinical-research groups in Turkey and Germany. Hardware combines an ear clip with paired auxiliary electrodes for specific protocols (vagus only, vagus + acupoint, etc.). Less brand recognition outside the EU than Nurosym, thinner evidence than Nurosym, and a wider protocol library.
How we tested: Evidence-based assessment — scored from Vagustim Health product documentation, published independent and collaborator trials and 2026 EU market reviews. Not hands-on tested by ONDA.
CE-marked Class IIa medical device. Independent studies on HRV, anxiety and depression count; company-collaborator studies do not count as evidence in ONDA scores.
Stimulation mechanism
7.5
Auricular tVNS via tragus clip, plus paired electrode protocols. Documented stimulation parameters configurable per protocol.
Protocol flexibility
8.0
Library of protocol presets (stress, sleep, depression, anxiety, IBS), each with disclosed parameters. Stronger protocol variety than Nurosym.
Comfort and wearability
7.0
Tragus clip plus secondary electrode pads. Slightly more setup than a single ear clip; well-tolerated for 20-30 minute sessions.
Biofeedback and data
6.5
Companion app logs sessions and self-rated state; no on-device HRV.
Value
7.0
~€499 (~$540) hardware, no subscription. Mid-pack pricing for a research-backed device.
Pros
+CE-marked Class IIa medical device — EU regulatory backing
+Wider protocol library than Nurosym with disclosed parameters
+Independent and collaborator-published trial base on HRV and anxiety
+No subscription required
Cons
−Less brand recognition than Nurosym outside the EU
−Multi-electrode setup is more involved than a single ear clip
−No on-device HRV biofeedback
−Customer support and warranty processes weaker outside EU markets
Price: $540 €499 — one-time; no subscription (as of 2026-05-21)
Where it leads
Vagustim is the strongest non-Nurosym auricular tVNS device on evidence. It is CE-marked as a Class IIa medical device, and the trial base — from Turkish and German clinical-research groups — covers HRV modulation, depression, anxiety and IBS protocols. Where Nurosym ships a single, deliberately spartan programme, Vagustim layers a library of protocol presets on top of the ear clip, each with disclosed pulse parameters configurable per condition.
What are the downsides of Vagustim?
Distribution is the constraint. Brand recognition outside the EU is thin, customer support and warranty processes vary by region, and the multi-electrode setup (tragus clip plus secondary pads for some protocols) is more involved than a single ear clip. For a first-time user that adds friction. There is no on-device HRV measurement — like every other ear-clip device here, biofeedback has to come from a paired wearable.
Who should buy Vagustim?
Choose Vagustim if you are in an EU market, accept a thinner evidence base than Nurosym’s, and prefer a wider protocol library to a single deliberately constrained programme. If you are outside the EU, Nurosym’s distribution and support are more reliable. If you want fewer electrodes and a phone-app driven UX, Pulsetto is closer to that shape.
Background reading
The biology behind what these devices target — and the protocols that compound with the hardware.
Vagus nerve exercises — why the vagus nerve sits upstream of HRV, sleep, mood and inflammation
Vagustim is worth it for EU users wanting protocol variety with solid evidence. It is a CE-marked Class IIa medical device with a wider, disclosed protocol library than Nurosym and a published trial base on HRV and anxiety, with no subscription. Setup is more involved than a single ear clip.
How much does Vagustim cost?
Vagustim costs €499, about $540, as a one-time purchase. No subscription is required to use its protocol library, which is wider than Nurosym's and comes with disclosed stimulation parameters.
Vagustim vs Nurosym: which is better?
Vagustim offers a wider protocol library with disclosed parameters and thinner evidence. Nurosym has stronger brand recognition outside the EU and a simpler single-ear-clip setup. Choose Vagustim for protocol variety in EU markets.
What are the downsides of Vagustim?
Vagustim has less brand recognition than Nurosym outside the EU, a multi-electrode setup more involved than a single ear clip, and no on-device HRV biofeedback. Support and warranty processes are weaker outside EU markets.
